Natco Pharma has announced a key technical product from its Crop Health Sciences (CHS) division for Chlorantraniliprole (CTPR), a broad-spectrum insecticide used in several crops.
The company hopes to bring formulations based on this product with affordability and accessibility to farmers across the country, and is awaiting regulatory approval for the CTPR product.
CTPR is an active ingredient used in products commercialised by FMC under their brands Coragen and Ferterra.
The sales generated from CTPR-containing products in India, inclusive of third-party marketing companies, as per declaration given by FMC is estimated to be Rs 1,540 crore in 2016.
The company filed a suit for declaration of freedom to use of CTPR, at the City Civil Court, Hyderabad, earlier this year. Following Natco's action, FMC counter-sued before the Delhi High Court, in November 2019, claiming patent infringement.
